Aspen Acquires AstraZeneca Anesthetics Portfolio Ex-US

Continuing its divesture of non-core assets, AstraZeneca PLC has licensed rights to its global anesthetics portfolio outside the US to South Africa's Aspen Global Incorporated

Magnifying glass

More from Business

More from Scrip